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CUG-BP1 (CUG-binding protein 1 also called CELF1) is a human RNA-binding protein that has 
been implicated in the control of splicing and mRNA translation. The Xenopus homologue 
(EDEN-BP) is required for rapid deadenylation of certain maternal mRNAs just after fertilisation. 
A variety of sequence elements have been described as target sites for these two proteins but their 
binding specificity is still controversial. Using a SELEX procedure and recombinant CUG-BP1 
we selected two families of aptamers. Surface Plasmon Resonance and Electrophoretic Mobility 
Shift Assays showed that these two families differed in their ability to bind CUG-BP1. 
Furthermore; the selected high affinity aptamers form two complexes with CUG-BP1 in 
electrophoretic mobility assays whereas those that bind with low affinity only form one. The 
validity of the distinction between the two families of aptamers was confirmed by a functional in 
vivo deadenylation assay. Only those aptamers that bound CUG-BP1 with high affinity conferred 
deadenylation on a reporter mRNA. These high affinity RNAs are characterised by a richness in 
UGU motifs. Using these binding site characteristics we identified the Xenopus maternal mRNA 
encoding the MAP kinase phosphatase (XCl100) as a substrate for EDEN-BP. In conclusion, 
high affinity CUG-BP1 binding sites are sequence elements at least 30 nucleotides in length that 
are enriched in combinations U and G nucleotides and contain at least 4 UGU trinucleotide 
motifs. Such sequence elements are functionally competent to target a RNA for deadenylation in 
vivo. 
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 CUG-BP1 (CUG-binding protein 1) is a human RNA-binding protein that was first 
identified by its capacity to bind to a (CUG)8 probe [1, 2]. It was thereby implicated in type 1 
Myotonic Dystrophy (DM1, MIM #160900) which is a neuromuscular disease associated with an 
unstable CUG triplet expansion in the 3' untranslated region (3'UTR) of the myotonin protein 
kinase gene (DMPK). A variety of functions have been described for CUG-BP1 (reviewed in 
[3]). In the nucleus, it was demonstrated to control the alternative splicing of certain pre-mRNAs 
[4-10]. In the cytoplasm, it stimulates the translation of p21 mRNA [11], or controls the choice of 
translation initiation codon of C/EBP mRNA [12]. The Xenopus equivalent of CUG-BP1, 
EDEN-BP (Embryo Deadenylation ElemeNt-binding protein), is responsible for the rapid 
cytoplasmic deadenylation (poly(A) tail shortening) of certain maternal mRNAs [13], that is 
correlated with translational repression [14]. In Xenopus egg extracts the human CUG-BP1 and 
Xenopus EDEN-BP are interchangeable [15] and recently, CUG-BP1 was reported to act as a 
deadenylation factor in human cells by recruiting PARN deadenylase to target mRNA [16]. 
Lastly, CUG-BP1 is one of the founding members of the CELF (CUG-BP1 and ETR-3 Like 
Factors) family of RNA-binding proteins [17] that are key molecular actors which determine the 
fate of a large number of mRNA (reviewed in [3]). 
 Despite the importance of CUG-BP1 and related proteins in the post-transcriptional 
regulation of gene expression, the sequence requirements for high affinity CUG-BP1 binding are 
still ambiguous. This protein was initially reported to cross-link DMPK 3'UTR CUG expansion 
[1]. Other natural sequences described for their capacity to bind to CUG-BP1 include U/G-rich 
intronic motifs [4, 18, 19], 3'UTR U/G-rich motifs such as the c-jun AU-rich element (ARE) 
[20], c-mos EDEN [15], and GCN-rich coding regions [12, 21, 22]. However, the capacity of 
CUG-BP1 to bind to the CUG expansion has been questioned [23, 24]. In two independent triple 
hybrid assays using synthetic probes, it was observed that CUG-BP1 had a low affinity for CUG 
repeats but interacted very efficiently with (UG)n probes [24, 25]. In addition, CUG-BP1 cross 
links to a synthetic (UG)15 probe [26]. The sequence requirement for CUG-BP2/CELF2/ETR-3, 
that shares 75% identity with CUG-BP1 (and almost 100% identity in the consensus RNA 
binding domains [3]), is also ambiguous. RNA aptamers selected against this protein resulted in 
UG-rich sequences and in particular UGUU motifs [27], but this protein was also shown to 
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interact with cycloxygenase 2 mRNA ARE [28]. This ARE is not UG-rich but rather contains 
several AUUUA motifs.  
 This variety in the sequences reported to be recognised by CUG-BP1, and the ambiguity 
of autonomous binding, highlights the need for a systematic, non-biased (without prior 
limitations), examination of the binding specificities of this protein. In this work, we have used a 
SELEX procedure (Systematic Evolution of Ligand by EXponential enrichment) [29, 30] to 
select RNA aptamers from a library of random sequences on the basis only of their autonomous 
association with CUG-BP1. Analysis of the binding affinities and the functionality of the selected 
aptamers showed that a minimal high affinity CUG-BP1 binding site could be defined as a 
relatively short RNA (around 36 nucleotides) highly enriched in UG repeats with a particular 
importance of the UGU motif. These criteria was used to identify a biologically important 
maternal Xenopus mRNA MAP kinase phosphatase (XCl100 alpha) that is a target for the 
Xenopus homologue of CUG-BP1. 
 
EXPERIMENTAL . 
Recombinant protein production 
CUG-BP1 open reading frame was cloned in the pTRC-His plasmid (Invitrogen). His-tagged 
protein was produced by overnight induction at 25°C with 5 mM IPTG and purified on Ni-NTA 
agarose beads (Qiagen) following the manufacturer's instructions. Denaturing electrophoresis and 
Coomassie blue staining was used to check the purity of recombinant CUG-BP1 and to measure 
its concentration as compared with several BSA concentrations. 
 
Synthesis of the initial random RNA library 
The initial random oligonucleotide was purchased from IBA GmbH/Göttingen. The sequence is 
5'-CCACTAAACCAGCCTCAAGGGTACCGCTCTAGA(35N)GCTAGCGTATCTGCTCCTA 
ATAAAAAGAGGATCCCC-3' where N represents the randomised part and the underlined 
sequences are XbaI and NheI restriction sites respectively. This oligonucleotide was PCR 
amplified (4 cycles) using the Forward (5'-
AGTAATACGACTCACTATAGGGCCACTAAACCAGCCTCAAGG-3') and Reverse (5'-
GGGGATCCTCTTTTTATTAGG-3') primers to generate a double stranded DNA template with 
a 5'-end T7 promoter (underlined in the Forward primer). Each 100 μl PCR reaction contained 8 
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pmol of random oligonucleotide template and 2.5 U of Amplitaq DNA polymerase (Perkin 
Elmer). The PCR products were phenol/chloroform extracted, ethanol precipitated and further 
purified on Microcon YM30 columns (Amicon). The initial RNA pool was synthesised from 240 
pmol of PCR DNA with 2400 U of T7 RNA polymerase (New England BioLabs) in a 6 ml 
reaction mixture supplemented with 24 U of inorganic pyrophosphatase (Sigma) and 300 U of 
porcine RNAse inhibitor (Amersham Biosciences). After 4 h at 37°C, the reaction was treated (30 
min at 37°C) with 700 U of DNAse I (Invitrogen). The RNA mixture was extracted with 
phenol/chloroform and chloroform (twice), ethanol precipitated and further purified on YM30 
Microcon columns. The RNA was eluted by using the SELEX binding buffer (50 mM Tris-HCl, 
pH 7.5, 50 mM NaCl, 5 mM DTT and 0.1 mM CaCl2). 
 
SELEX procedure 
 RNA (300 pmol) was refolded by heating at 85°C and slowly cooled to room temperature 
before counter selection through a HAWP filter (Amicon). RNA was then incubated with CUG-
BP1 (30 pmol) for 80 min (first round) or 30 min (subsequent rounds) in the presence of 1.2 nmol 
of tRNA (Ambion). Partition was achieved by filtration through a HAWP filter that was washed 
three times with 200 μl of binding buffer. The filter was incubated 5 min at 85°C in the elution 
buffer (7 M urea, 100 mM sodium citrate and 3 mM EDTA) to recover the CUG-BP1 associated 
RNA species that were isopropanol precipitated. The RNA was refolded in binding buffer and 
subjected to a second counter selection as described above. The eluted RNA was ethanol-
precipitated and resuspended in nuclease free water. 
 After each round of selection the RNA was hybridised with the Reverse primer, reverse 
transcribed with 15 U of AMV reverse transcriptase (QBiogen) during 50 min at 42°C and PCR 
amplified with 30 U of Amplitaq DNA Polymerase as described for the initial RNA pool. The 
PCR products were purified on a YM30 Microcon column and 18 pmol of DNA were in vitro 
transcribed with 200 U of T7 RNA polymerase for 3 h at 37°C. Finally, the RNA was treated 
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Individual aptamers were cloned from a retro-transcribed RNA pool using TA cloning procedure 
(Invitrogen) with pCR2.1 TOPO plasmid as described by the manufacturer. The DNA of interest 
was PCR amplified from individual positive bacteria colonies using M13-Forward and Reverse 
primers and sequenced. The random sequences were extracted and analysed using the Clustal W 
algorithm [31] and Emboss web facility. 
 
Evaluation of RNA affinity 
 Individual or pooled clones were PCR amplified using the Forward (that contains a T7 
promoter) and Reverse primers and Amplitaq DNA polymerase. The PCR products were purified 
and quantified. The RNAs were transcribed in the presence (for Electrophoretic Mobility Shift 
assay, EMSA) or the absence (for Surface Plasmon Resonance, SPR) of α32P-UTP. The plasmids 
encoding the s3'Eg5 and s3'Eg5C6 RNAs have been described [13] and were used as 
transcription templates as above. EMSA was performed as described by Cosson et al [32].The 
SPR experiments were performed using a BIAcore 2000 biosensor system (BIAcore) at 25°C 
according to the manufacturer's instruction. CUG-BP1 was immobilised directly on a CM5 
sensor chip (BIAcore) using amine coupling kit (BIAcore). This was preferred to attachment via 
a tag because two of the three RNA Recognition Motifs in CUG-BP1 are very close to the N- and 
C-termini and immobilisation via a N- or C-terminal tag could interfere with the overall CUG-
BP1 RNA recognition specificity. A blank flow cell (without protein) was used to evaluate non-
specific interactions. RNA was diluted to 100 nM in the running buffer (10 mM HEPES, pH 7.9, 
150 mM NaCl, 1 mM MgCl2, 0.1 mM CaCl2 and 0.05% Tween 20) supplemented with 0.2 U/μl 
SuperasIn (Ambion), and injected for 2 min followed by a 2 min dissociation step at a flow rate 
of 20 μl/min. Regeneration was achieved with a 6 s pulse of 100% ethylene glycol at a flow rate 
of 50 μl/min. Each RNA sample was injected once before performing the second injection (serial 
duplicates procedure). The sensorgrams were analysed using the BIAevaluation software (version 
3.2, BIAcore).  
 
 
In vivo deadenylation assay and analysis of maternal Xenopus mRNA. 
 DNA corresponding to the RNA aptamers were digested by NheI and XbaI, and cloned 
into pGbORF/mosEDEN plasmid in place of the minimal c-mos EDEN [13]. The 3'UTR of 
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XCl100 alpha maternal mRNA was amplified by PCR (forward primer 
(5'CTAGCTAGCGGTACTGAGCAAACAGAC; reverse primer 
5'CGGGATCCCAGTACAAATATCATAATTTA) and cloned into the NheI and BamHI 
restriction sites of pGbORF [33]. The globin reading frame was then deleted by restriction by 
NheI (blunt ended) and SacI and religation. All constructs were sequenced. 
 Capped, polyadenylated radiolabelled RNA were microinjected in Xenopus 2-cell 
embryos and the deadenylation assays were performed as already described [13]. Briefly, RNAs 
were extracted with Tri-Reagent (Euromedex) and separated by electrophoresis on 4% 
polyacrylamide gels containing urea. The dried gels were analysed using a Phosphoimager 
(STORM 840, Molecular Dynamics). The proportion of fully deadenylated RNA was quantified, 
using the ImageQuant software (Version 5.4, Molecular Dynamics), by determining the signal in 
a rectangle at the position of the fully deadenylated transcript (A)0 relative to the total signal of 
this transcript (fully adenylated, partially and totally deadenylated transcripts). 
To analyse Xenopus maternal mRNAs, total RNA was extracted from embryos using Tri-
Reagent (Euromedex) and separated into poly(A)+ and poly(A)- population by oligodT cellulose 
chromatography (Promega). The RNAs were analysed by Northern blotting. XCl100 alpha 
mRNA was revealed using 32P-labelled cDNA probes corresponding to the coding sequence 
(plasmid obtained from Dr J.E. Fenell Jr. Sanford, Ca, USA; Accession number AJ320158). 
Immunoprecipitations and UV-induced cross-linking, using the indicated 32P-labelled RNAs, 
were performed as previously described [13]. The XCl100 alpha RNA corresponded to the UGU 




The SELEX procedure against CUG-BP1 
 A SELEX procedure was developed that could generate fully functional CUG-BP1 RNA 
aptamers. An initial SELEX RNA library of 1.8x1014 distinct RNA sequences, randomised on 35 
positions, was used (see Experimental). The 35 nucleotide random sequence was flanked by 
invariant 5' and 3' regions derived from the β-globin 3'UTR (Figure 1A). After an initial counter 
selection to remove non-specific RNA species, the RNA pool was incubated with CUG-BP1 and 
loaded onto the filter. Bound RNA was eluted from the filter and submitted to a second counter 
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selection. The RNA was then amplified by RT-PCR, transcribed into a new RNA library and then 
applied to the next round of selection/amplification. This selection/amplification procedure was 
repeated 7 times but with a reduced incubation time to increase stringency. Throughout the 
experiments, the same preparation of recombinant, bacterially-produced CUG-BP1 protein was 
used. The integrity and purity of this protein were verified by SDS-PAGE (Figure 1B). 
 
Evaluation of the enrichment using a SPR biosensor and EMSA. 
 To evaluate the quality of the SELEX enrichment after 8 rounds of selection, two 
analytical methods were used, a SPR assay using a BIAcoreTM 2000 instrument and EMSA. The 
SPR assay was used for screening as it is rapid and can be automated. However, a high level of 
CUG-BP1 immobilisation (about 10000 Resonance Units) was necessary to detect a clear 
association signal with c-mos EDEN RNA (positive control, see Figure 2B). A high 
immobilisation level on the chip causes mass transport limitations in the proximity of the sensor 
chip surface [34] which prevents analysis of the kinetics of RNA:protein associations. Therefore, 
we used a ranking analysis which consisted of comparing the overall qualitative shape of specific 
binding figures (sensorgrams) to determine the end-point association level (in RU) reached after 
injection of each analyte [35, 36]. When all the samples are injected under the same conditions 
(concentration, volume, flow rate, temperature), the endpoint value should be directly correlated 
with RNA affinity. The validity of this SPR method for the present case was demonstrated by the 
close correlation between the SPR and EMSA results (see below). 
 First, the specificity and the sensitivity of both assays were assessed by running individual 
RNA sequences. Except where indicated, EMSA assays were performed with 4-fold serial 
dilutions of CUG-BP1, between 0.5 and 2000 nM. The S0(1) RNA was randomly taken from the 
cDNAs cloned from the starting pool of unselected aptamers. No association of this RNA with 
CUG-BP1 was detected by either the SPR assay or EMSA (Figure 2A). The c-mos EDEN, 
previously described as a good CUG-BP1 target in a UV cross-linking assay [15], was used as a 
positive control. This RNA presented a strong association in the SPR assay, reaching an end-
point value around 45 RU (Figure 2B, left panel). In the EMSA (Figure 2B, right panel) 
increasing amounts of CUG-BP1 shifted this RNA from the free state to a first (C1), and then a 
second (C2) complex. The affinity of CUG-BP1 for c-mos EDEN was estimated from the 
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concentration of protein that bound 50% of the RNA probe. This value, which would be the Kd if 
only one complex was formed, was 25±6 nM (average of three independent experiments). 
 Pools of RNA were next tested. In both SPR and EMSA, the initial RNA library (S0 pool) 
behaved very similarly to the S0(1) RNA, demonstrating that the S0 pool had no overall affinity 
for CUG-BP1 (Figure 2C). In contrast, the enriched RNA pool (S8 pool) gave an association 
signal in the SPR assay, and this pool of RNA was shifted to two different complexes by 
increasing concentrations of CUG-BP1 in the EMSA (Figure 2D). The "fuzzy" appearance of the 
shifted complexes in the EMSA using the S8 pool (Figure 2D, right panel) may be due to the 
heterogeneity of the RNA population. The different sequences forming this pool may have 
different conformations and hence have different electrophoretic mobilities. This dispersion of 
the bands also reduces the precision of the quantification of the affinity of this pool of RNA for 
CUG-BP1 (115±27 nM). Irrespective of these considerations, the results in Figure 2 show that 
the SELEX procedure had successfully allowed the evolution of the large random RNA library 
into an enriched RNA population whose global affinity was similar to that of the c-mos EDEN. 
Four additional SELEX rounds did not increase the overall affinity of the RNA library (data not 
shown). 
 
Characterisation of individual aptamers after round 8 
 The cDNA libraries corresponding to RNA aptamers (S0 pool and S8 pool) were cloned 
and randomly selected clones were sequenced. As expected, no sequence similarity was detected 
in 41 clones from the S0 pool. The sequences of 101 clones from the S8 pool are given in the 
Supplementary data (Supplementary Figure 1). For these S8 clones, although no consensus 
sequence or obvious conservation was detected, the Clustal algorithm (ClustalW) identified two 
families of aptamers. In family 1, containing 63 clones, the aptamers were enriched in uridine and 
depleted in adenosine and cytosine nucleotides relative to the 41 clones from the S0 pool. The 
nucleotide composition of the second family (38 clones) was not significantly different from that 
of the S0 pool. Within the 38 clones of family 2, a subpopulation of 10 clones containing 6 
different sequences (S8(2) is present in 5 copies) displayed a conserved motif in the 3’region 
(GUUCUGCUAGUUU(U/C)GGUU) (see Supplementary Figure 1). 
 SPR and EMSA analyses were performed on seven individual aptamers from the S8 pool. 
In EMSA assays, two of them, S8(12) and S8(13), that both belong to family 2, were not shifted 
Biochemical Journal Immediate Publication. Published on 29 Aug 2006 as manuscript BJ20060490
Copyright 2006 Biochemical Society
The final Version of Record is available at www.biochemj.org
Marquis et al. Biochem. J. revised  24/07/06 
 10
by CUG-BP1 (Figure 3). In the SPR assay, the same RNAs gave no association signal (see Table 
1). In contrast, S8(5), S8(6), S8(7) and S8(8), that all belong to family 1 and S8(2) that belongs to 
family 2, showed association with CUG-BP1 in EMSA (Figure 3) and SPR (Table 1) assays. 
However, there was a noticeable difference between the EMSA patterns of these RNAs. S8(5), 
S8(6) and S8(7) produced the slower mobility complex, C2, (complex C1 was also observed at 
low CUB-BP1 concentrations) but only the fast mobility complex, C1, was observed for RNAs 
S8(2) and S8(8). These differences in EMSA pattern were reflected in the affinity of the 
individual RNAs for CUG-BP1 as estimated from the EMSA or the SPR assay (see Figure 3 and 
Table 1). The three RNAs that produced the C2 complex had an affinity for CUG-BP1 
comparable to that of c-mos EDEN. For the two RNAs, S8(2) and S8(8), which only formed the 
C1 complex, at least 20 fold more protein was required to shift 50% of the probe. 
 The results shown in Figures 2 and 3 and Table 1 demonstrate an excellent agreement 
between the SPR and EMSA results obtained with the individual RNAs. Hence, 6 additional 
aptamers from the S8 pool were analysed by SPR alone; 2 were from family 1 and 4 from family 
2 of which 3 came from the subpopulation with the conserved motif. Based on the end-point 
values, the two RNAs from family 1, S8(9) and S8(10), showed a high affinity for CUG-BP1 
whereas none of the RNAs from family 2 displayed any binding to CUG-BP1 (see Table 1). This 
result indicates that the sequence present in several RNAs of family 2 is not implicated in binding 
to CUG-BP1 as determined by the assays used here. 
 
Functionality of SELEX aptamers 
 The SPR and EMSA assays allowed us to discriminate between the two aptamer families 
initially defined on a basis of ClustalW alignment. To biologically confirm this discrimination we 
used an in vivo test. In Xenopus embryos, EDEN-BP, the equivalent of human CUG-BP1, acts as 
a sequence specific factor that directs target RNA for deadenylation [13]. For this process EDEN-
BP can be replaced by the orthologous CUG-BP1 [15]. Therefore we used a deadenylation assay 
to evaluate aptamer functionality. The sequences to be tested were cloned in the 3'UTR of a β-
globin cDNA upstream of a synthetic polyA tail (A)65. The corresponding radiolabelled RNA 
was injected into Xenopus embryos and samples were taken at hourly intervals to follow 
deadenylation kinetics. The deadenylation-targeting activities of the tested aptamers were 
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compared to that of a similar mRNA but containing the c-mos EDEN in the 3'UTR (c-mos 
EDEN). 
 As already reported, c-mos EDEN RNA (Figure 4A, top panel) was deadenylated by the 
EDEN pathway with the characteristic accumulation of the deadenylated ((A)0) mRNA within 1 
to 2 hours while fully adenylated ((A)65) mRNA persists [13]. In the experiment shown in Figure 
4A, top panel, a completely deadenylated form of this transcript ((A)0) was detected as soon as 1 
hour after injection (lane 2) and, 4 hours after injection, the (A)0 band was very abundant (lane 5). 
In Xenopus embryos, the (A)0 mRNAs are stable for at least 6 h [33, 37]. The deadenylation 
pattern observed for the control c-mos EDEN RNA was compared with those conferred by one 
aptamer from family 1 that bound CUG-BP1 with high affinity, S8(7), one aptamer from family 2 
with low affinity ,S8(2) and one aptamer from family 2 for which no CUG-BP1 binding had been 
detected, S8(12) (See Table 1). The deadenylation of the RNA containing the S8(7) aptamer 
(Figure 4A, middle panel) presented the characteristics of EDEN-dependent deadenylation, with 
a (A)0 band easily detectable 2h after injection and abundant after 4h (lane 5). In contrast, the 
mRNA containing the S8(12) and S8(2) sequences (Figure 4A, two bottom panels) were not or 
only very slowly deadenylated. No deadenylated molecules (A)0 could be detect before 4h of 
incubation (Figure 4A). Quantification of these experiments (Figure 4B) showed that the 
deadenylation kinetics of S8(7) and c-mos EDEN mRNAs were similar whereas that of S8(2) and 
S8(12) was about 5 times slower. 
 
A threshold number of UGU for efficient CUG-BP1 binding 
To better characterise the RNA sequence requirements for CUG-BP1 binding, the 
nucleotide composition of the sequenced RNAs from family 1 and 2 were analysed and compared 
to that of the 41 sequenced RNAs from the S0 pool. The graphical presentation of the proportions 
of mono-, di-, tri and tetra-nucleotides in the sequenced RNAs from family 1 and 2 and the S0 
pool are given in the supplementary data (Supplementary Figure 2). The most notable features of 
these analyses were an enrichment in the family 1 RNAs of U mono-nucleotides and certain di 
and tri nucleotides containing different combinations of U and G nucleotides. In particular, UGU 
tri-nucleotides represented nearly 20% of all the tri-nucleotides in the family 1 RNAs. 
In Table 1 is reported the number of UGU tri-nucleotides for the RNAs tested in the 
EMSA and SPR experiments described above. Sequences with 0 to 2 UGU do not bind, or bind 
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only weakly, to CUG-BP1, whereas sequences with 8 to 10 motifs bind strongly. Analysis of the 
number of UGU in the individual RNA sequences (Figure 5) showed that the RNAs in the S0 
pool and family 2 contain 2 or less UGU while those of family 1 contain 4 or more UGU. 
Importantly, more sequences are found with 6 UGU than with 4 UGU suggesting that aptamers 
with 6 UGU were more efficiently selected during the SELEX procedure than aptamers with 4 
UGU. In contrast, more than 6 UGU does not appear to confer a selection advantage on an 
aptamer relative to those with 6 UGU. This suggests that efficient binding sites for CUG-BP1 
consist of sequences containing at least 4 to 6 UGU. Accordingly, a sequence containing 5 UGU 
was tested. The EDEN motif in the 3' portion of the Xenopus Eg5 mRNA (s3'Eg5) contains 5 
UGU [13] (Table 1). EMSA analysis demonstrated that the affinity of the s3'Eg5 RNA is 
comparable to that of the c-mos, S8(5), S8(6) and S8(7) RNA (Figure 3, Table 1), confirming that 
a threshold for efficient binding occurs between 4 and 5 UGUs. The binding affinity of a mutant 
RNA (s3'Eg5C6), in which three UGU trinucleotides were changed to cytosines, was next 
determined. This mutation reduces the number of UGU's from 5 to 2 (Table 1), which is below 
the proposed threshold. No retarded complex was observed for the s3'Eg5C6 RNA by EMSA, 
demonstrating a much reduced affinity (Figure 3, Table 1). Together, these data indicate that the 
main sequence requirement for affine binding to CUG-BP1 is the presence of at least 5 UGU 
within a 35 nucleotides window. 
 
Identification of a maternal Xenopus mRNA containing a CUG-BP1/EDEN-BP binding 
site. 
 In Xenopus embryos the majority of maternal mRNAs that are known functional targets 
for EDEN-BP, encode kinases important for the cell cycle. Therefore, to relate the sequence 
requirements for CUG-BP1/EDEN-BP binding to a biologically important event we searched 
3'UTR sequences of Xenopus mRNAs encoding kinases or phosphatase for a potential novel 
target using the criteria defined above. This analysis identified the MAP kinase phosphatase 
XCl100 alpha [38] whose 3'UTR contains 12 UGU tri-nucleotides within a 35 nucleotide stretch 
(Accession number of mRNA, AJ320158) making it a potential target for EDEN-BP, which 
would limit the expression of this protein after fertilisation. This mRNA is of particular interest 
to the present study as the over expression of XCl100 alpha mRNA in embryos causes severe 
defects in gastrulation and posterior development [39] (and unpublished data). 
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To ensure that the endogenous XCl100 alpha mRNA is a potential target for CUG-
BP1/EDEN-BP the adenylation behaviour of the maternal mRNA was determined. Total mRNA 
extracted from embryos at 0h, 2h and 4h after fertilisation were fractionated into poly(A)+ and 
poly(A)- populations and analysed by Northern blot (Figure 6A). As already observed for a 
number of maternal Xenopus mRNAs [40] the amount of XCl100 alpha mRNA in the total 
population did not vary over this 4h period. In contrast, there was a reciprocal exchange of this 
mRNA between the poly(A)+ and poly(A)- populations. The majority of XCl100 alpha mRNA, 
that is in the poly(A)+ population at fertilisation (0h), rapidly becomes deadenylated. 
Next, a radiolabelled RNA corresponding to the 180 nt portion of the XCl100 alpha 
3'UTR that encompasses the UGU rich motif was synthesised and used in a uv-induced cross 
linking assay with Xenopus egg extracts (Figure 6B). In parallel with this RNA, the RNA Gb 
ORF and GbORF c-mos were included as negative and positive controls respectively. Both the 
XCl100 alpha and GbORF c-mos RNA produced a strong radioactive signal for a protein 
migrating as wide band between 54 and 56 kDa which is characteristic of Xenopus EDEN-BP 
[13]. The identity of this protein was confirmed by immunoprecipitation of the radiolabelled 
protein with anti-EDEN-BP antibodies (data not shown). 
To verify that the 3'UTR of XCl100 alpha could confer the deadenylation behaviour 
observed for the maternal mRNA we analysed the adenylation behaviour of a reporter mRNA 
containing this sequence after injection into Xenopus embryos (Figure 6C). This reporter mRNA 
was rapidly deadenylated with kinetics similar to those already described for the reporter mRNA 
containing the c-mos EDEN (compare Figure 4A and 6C). Together these results show that the 
3'UTR of XCl100 alpha targets an mRNA for rapid EDEN-dependent deadenylation in Xenopus 
embryos and therefore further validate the UGU-richness of the 3'UTR as a pertinent criterion to 
identify novel CUG-BP1/EDEN-BP mRNA targets. 
 
DISCUSSION 
 A population of RNA (S8 pool) with a global affinity for CUG-BP1 equivalent to that of 
the c-mos EDEN was obtained after 8 rounds of SELEX. Sequencing of 101 clones from this S8 
pool did not identify any consensus motif, but allowed the clustering of these sequences into 2 
families. The affinity of 13 individual aptamers was measured which showed that the majority 
(5/6) of tested family 1 RNAs had a high affinity for CUG-BP1 and produced two shifted 
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complexes (C1 and C2) in EMSA. Family 2 RNAs had no or a low (1/7) affinity for CUG-BP1 
and the low affinity aptamers produced only the faster mobility complex (C1). In an in vivo 
deadenylation assay the family 1, but not the family 2, aptamers conferred efficient deadenylation 
on a reporter mRNA. 
Analysis of the sequenced aptamers showed, for family 1, that UGU triplets represented 
approximately 20% of all the trinucleotides, and that at least 4 non-overlapping UGU are found 
in these aptamers. The number of UGU trinucleotides in the family 2 aptamers was not 
significantly different from that in the S0 pool. The importance of the UGU trinucleotide for 
CUG-BP1 binding was demonstrated by EMSA using the Eg5 EDEN and a mutant form that 
decreased the number of UGU trinucleotides from 5 to 2. This mutation drastically reduced the 
affinity of the RNA for CUG-BP1.  
 These data indicate that most functional CUG-BP1 binding sites will probably be 
sequences of more than 30 nucleotides containing at least 4 non-overlapping UGU motifs. Using 
this information we identified the Xenopus maternal mRNA encoding the MAP kinase 
phosphatase XCl100 alpha as a substrate for the deadenylation process targeted by CUG-
BP1/EDEN-BP. Gotoh et al [39] have previously shown that the over expression of XCl100 
alpha in Xenopus embryos caused severe defects during gastrulation and in posterior 
development. These and our present data imply that the post-fertilisation deadenylation of the 
maternal mRNA, directed by the deadenylation factors CUG-BP1/EDEN-BP, is necessary in 
order to limit the amount of XCl100 alpha expressed in the embryo. Furthermore, it shows that 
the criteria defined for autonomous binding of CUG-BP1 or the Xenopus homologue EDEN-BP 
can be used to identify functionally important mRNAs. 
All but one of the sequenced aptamers of family 1 fulfil the criteria stated above 
(Supplementary data) and this is also the case for natural sequences previously identified by their 
capacity to bind CUG-BP1. These include the cTNT [4] and the Clc-1 [19] mRNA precursors, 
the BRE element [41] and the c-jun ARE [20]. Moreover, we noted that mutations in the cTNT, 
Clc-1 and BRE sequences that abolished the interaction with CUG-BP1 [4, 19, 41] also disrupted 
these UGU motifs. CUG-BP1 was also shown to efficiently bind synthetic (UG)n repeats probes 
in UV cross link experiments [26] and triple hybrid assays [24, 25]. 
 Although the SELEX procedure produced a population of aptamers, S8 pool, that had 
overall affinity for CUG-BP1, this population contained a large proportion (about 38%) of 
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aptamers with low or no affinity for this protein. It should be noted that the SELEX procedure 
and the SPR and EMSA analyses do not use equivalent criteria or conditions. The binding and 
selection steps in the SELEX procedure were performed in conditions that selected aptamers with 
a range of affinities and also a number of false positive aptamers. Although the SPR and EMSA 
analyses discriminated between the high and low affinity sites, we can not formally exclude that 
the family 2 aptamers may represent binding sites that require auxiliary factors or are only used 
in certain cellular contexts.  
 The family 1 UGU-rich aptamers, tested for their ability to interact with CUG-BP1 
(S8(5), S8(6), S8(7) and c-mos EDEN) form two complexes, C1 and C2, in EMSA. In contrast, 
the two aptamers with a low affinity for CUG-BP1 that were tested, S8(2) and S8(8), only formed 
the first complex, C1. The different complexes could correspond to different conformations of the 
RNA probes associated with a single CUG-BP1 protein. However, this explanation would mean 
that, as the CUG-BP1 concentration increased, all the family 1 RNAs tested (including those in 
the S8 pool) but not the RNAs from family 2 would be able to take up two different 
conformations; we consider this unlikely. An alternative explanation is that the protein 
components of the two complexes are different. Although we can not exclude that the minor 
contaminants in the recombinant CUG-BP1 preparation partake in these complexes we think that 
this is improbable. We previously showed that EDEN-BP could form a homodimer in a yeast 
two-hybrid assay [42] and we have now demonstrated that this can occur in vivo [32] Therefore, 
we prefer the explanation that the two complexes correspond to different oligomerisation states of 
CUG-BP1 bound to the RNA probe. 
 What are the RNA binding specificities of proteins close to human CUG-BP1? In human, 
CUG-BP1 is a member of the Bruno-like (BRUNOL) or CELF family of RNA-binding proteins 
[17, 41] reviewed in [3]. The best known member of this family, with CUG-BP1, is ETR-3 (also 
named CUG-BP2 or BRUNOL3), that shares 75% identity with CUG-BP1. This protein was 
shown to bind to an AU-Rich element in Cyclooxygenase-2 mRNA that is not enriched in UGU 
trinucleotide [28], which suggests a different binding specificity between CUG-BP1 and ETR-3. 
However, an ETR-3 SELEX selected sequences enriched in UG and UGUU [27], which is closer 
to the sequence requirement for CUG-BP1. In addition, Suzuki et al [7] showed using UV-
crosslinking that CUG-BP1 and ETR-3 could bind to UG-rich sequences. Binding to motifs 
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enriched in UGU may therefore be a general property of at least these two BRUNOL/CELF 
proteins. 
 The proportion of CUG and GCN sequences decreased during the SELEX procedure (see 
Supplementary data) in contradiction with previously published data for CUG-BP1 targets [2, 12, 
21, 22]. Other authors also failed to find any affinity between CUG-BP1 and these sequences in 
three-hybrid assays [24, 25]. Moreover, CUG expansions form double-stranded RNA that is 
unable to bind CUG-BP1 [23]. This does not exclude that CUG-BP1 could bind to non-UGU rich 
elements when associated with particular co-factors. For instance, the association of CUG-BP1 
with another RNA-BP could significantly modify the characteristics of the element to which the 
complex is bound. For example, hnRNPE1 is involved both in the silencing of 15-lipoxygenase 
mRNA and the stabilisation of β-globin mRNA during erythroid differentiation, and these 
properties are mediated by binding to different sequences [43, 44]. Also, hnRNPD/AUF1 is 
involved in AU-rich element mediated mRNA degradation [45, 46] but belongs to stabilizing 
complexes that are associated with the coding region of c-fos mRNA [47] or the 3'UTR of α-
globin mRNA [48]. Again, the binding sites for AUF1 in these opposing functions are different.  
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FIGURE LEGENDS 
Table 1: CUG-BP1 affinity of individual aptamers 
The indicated cloned RNA aptamers were analysed by SPR and EMSA assays as described in the 
legend to Figure 2. The sequence of the aptamers and the number of UGU tri-nucleotides are 
indicated. The aptamers are ordered according to the SPR values that are the averages from two 
separate injections. The data for the EMSA assay give the concentration of CUG-BP1 (nM) 
required to shift 50% of the RNA probe (averages from three separate experiments). The families 
are defined on the basis of sequence criteria. The Xenopus EDEN sequences and that from the S0 
pool (S0(1)) are not clustered into a family. nd. Not determined. 
 
Figure 1: Overview of the SELEX procedure 
A, The 36 nucleotides invariant sequences of the random RNA library were those flanking the c-
mos EDEN in the GbORF/mosEDEN RNA. The Forward and Reverse primers, used for the PCR 
amplification steps, hybridise to approximately 20 nt of these invariant sequences. The Forward 
primer has a T7 promoter overhang (underlined). B, Coomassie blue staining of a sample of the 
recombinant CUG-BP1 used in the experiments (lane 2). Lane 1, molecular weight markers, sizes 
in kDa are given on the left.  
 
Figure 2: SPR and EMSA evaluations of SELEX enrichment 
The negative control (S0(1) RNA) (A), the positive control (c-mos EDEN RNA) (B), the initial 
random RNA population (S0 pool) (C) and the enriched RNA population (S8 pool) (D) were 
tested for their capacity to interact with recombinant CUG-BP1 by SPR (left panels) and EMSA 
(right panels) assays. For SPR, RNAs were injected at 100 nM over a sensor chip containing 
approximately 11000 Resonance Unit (RU) of immobilised CUG-BP1 (corresponding to 11 ng of 
CUG-BP1/mm2). The grey and the black curves represent the first and the second injection of 
each RNA sample. The end point values (in RU) correspond to the response signal reached at the 
end of the RNA injections (t = 120 s). For EMSA, uniformly labelled RNA probe was incubated 
with the following concentrations of CUG-BP1 (nM): lane 1, 0; lane 2, 0.5; lane 3, 2; lane 4, 8; 
lane 5, 31; lane 6, 125; lane 7, 500; lane 8, 2000. The free probe (F) and two complexes (C1 and 
C2) were resolved by native electrophoresis. The gel was dried and analysed using a 
phosphoimager and the ImageQuant software. The concentrations (nM) of CUG-BP1 required to 
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achieve 50% of shifted probe are indicated on the top of each gel (mean ± sd of three independent 
experiments). 
 
Figure 3: EMSA analysis of individual aptamers 
The indicated aptamers were analysed by EMSA for their capacity to bind CUG-BP1 as 
described in Figure 2. For the EMSA with the s3'Eg5 and s3'Eg5C6 RNAs the protein 
concentrations were (nM): lane 1, 0; lane 2, 1; lane 3, 2; lane 4, 4; lane 5, 8; lane 6, 17; lane 7, 
33; lane 8, 67; lane 9, 133 and lane 10, 266. The concentrations (nM) of CUG-BP1 required to 
achieve 50% of shifted probe are indicated at the top of each gel (mean ± sd of three independent 
experiments). The positions of the free probe (F) and the complexes C1 and C2 are indicated on 
the right of each panel. 
 
Figure 4: In vitro deadenylation assay of selected aptamers 
A, SELEX sequences (S8(2), S8(7), and S8(12)) and c-mos EDEN (mosEDEN) were cloned 
upstream of a synthetic (A)65 tail in the 3'UTR of a β-globin reporter gene. Capped, in vitro 
synthesised radiolabeled transcripts were micro-injected into Xenopus embryos. At different time 
points, total RNA was extracted from batches of embryos and analysed by electrophoresis on a 
denaturing polyacrylamide gel. The positions of the fully adenylated (A)65 and the fully 
deadenylated (A)0 forms of the transcripts are indicated on the left of each panel. B, 
Quantification of the experiments shown in A. The percentage of (A)0 RNA at each time point 
was calculated as described in the Materials and Methods. 
 
Figure 5: CUG-BP1 binding sites are enriched in UGU tri-nucleotides. 
The number of UGU tri-nucleotides in the individual sequenced aptamers of the S0 pool and 
family 1 and 2 are shown as a histogram. Family 1, grey bars; family 2, black bars; S0 pool, 
white bars. 
 
Figure 6: XCl100 alpha maternal mRNA is a target for EDEN-BP and is deadenylated after 
fertilisation. 
A) Maternal RNA isolated from unfertilised eggs (0h) or 2h and 4h after fertilisation was 
separated into poly(A+) and poly(A-) populations and analysed by Northern blotting. XCl100 
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alpha was revealed using a 32P-labelled probe as described in the Experimental. RNA loading was 
1 and 11 embryos equivalents for total RNA and poly(A+) or poly(A-) RNAs respectively. 
B) 32P-labelled RNAs containing the globin ORF with or without the c-mos EDEN, respectively 
gbORF and gbORFmos, and the UGU rich region of XCl100 alpha 3'UTR were incubated in 
Xenopus egg extracts and processed for uv-induced cross linking. After separation by SDS-
PAGE the proteins that had become radiolabelled were revealed by phosphoimager analysis. The 
positions of molecular weight markers (kDa) and of EDEN-BP are indicated on the right. 
C) Two cell Xenopus embryos were injected with a reporter mRNA containing the XCl100 alpha 
3'UTR. At the indicated times samples were taken for extraction and analysis of the RNA. After 
separation by electrophoresis on denaturing gels the radiolabelled RNAs were revealed by 
phosphoimager analysis. The position of the fully adenylated (A+) and deadenylated (A-) RNAs 
are indicated on the left. Lane M, RNA markers of 888 and 715 nt; lane A- the reporter RNA 
containing the XCl100 alpha 3'UTR synthesised devoid of a poly(A) tail. 
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Table 1.  
 






S8(7) 1 UAUGUUGUGUGUGUGUUGUUUUUGUGUUUUGUUUU 203 18 10 
S8(6) 1 UUAUUAUUGUUUAUUUUGUGUUGUGUGUUUGUGUU 151 6.4 8 
S8(5) 1 CCUGUGUCUUGUGUGUGUGUUUUGUUUCUGGUCUA 104 16 8 
S8(10) 1 CUAGCAGUUUGUGUGUGUGUGUGUGUGUUAUGCUA 70 nd 9 
c-mos 
EDEN 
none GUAUAUGUAUGUGUUGUUUUAUUGUGUGUGUGUGU 51 25 10 
S8(9) 1 UGUGUGUGUGUUAUUUUGUUCGUGUUAUUGUGAUCUA 48 nd 8 
s3'Eg5 none UAUAUAUGUGUGUCUAUCGUCACUUGUAUGUCAAAUAU
U 
nd 34 5 
S8(2) 2 CCCGGUUACCGUGUUUGUUCUGCUAGAUUUUGGUU 24 980 2 
S8(8) 1 AGCCGUCGCUAGUUUGAUUCCGUGUGUUAGUGGUU 19 510 2 
S0(1) none AGUACUCGACGGGACGGCUGCUGUGAACGACUACG 0 >2000  
S8(12) 2 GUGAUCCAAACCGUUUUUUCUGUCUCUCCAGUUUG 0 >2000 1 
S8(13) 2 UCGUAAAGGGCGUCGCUAAACUGAUUGCCGCUAGA 0 >2000 0 
S8(3) 2 GGCUGUACGCCUAUACGUUCUGCUAGAUUUCGGUU 0 nd 1 
S8(4) 2 GGUUUUAACCUACAUUGUUCUGCUAGAUUUUGGUU 0 nd 1 
S8(1) 2 UAAUCGUACUAUUUUUGUUCUGCUAGAUUUUGGUU 0 nd 1 
S8(11) 2 UGAAGACGUAAACCGGUUCUUCACGAUGUGGGUGU 0 nd 2 
S3'Eg5C6 none UAUAUAUCCCCCCUAUCGUCACUUGUAUGUCAAAUAUU nd >500 2 
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Figure 3 Marquis et al
Biochemical Journal Immediate Publication. Published on 29 Aug 2006 as manuscript BJ20060490
Copyright 2006 Biochemical Society
The final Version of Record is available at www.biochemj.org
AB
Figure 4 Marquis et al
Biochemical Journal Immediate Publication. Published on 29 Aug 2006 as manuscript BJ20060490
Copyright 2006 Biochemical Society









N° of UGU / sequence
0   1   2   3  4   5    6   7   8   9   10 11  12
Figure 5  Marquis et al.
Biochemical Journal Immediate Publication. Published on 29 Aug 2006 as manuscript BJ20060490
Copyright 2006 Biochemical Society
The final Version of Record is available at www.biochemj.org






























Biochemical Journal Immediate Publication. Published on 29 Aug 2006 as manuscript BJ20060490
Copyright 2006 Biochemical Society
The final Version of Record is available at www.biochemj.org
